BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31578284)

  • 21. JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications.
    Kasinath V; Beck C; Sauer P; Poepsel S; Kosmatka J; Faini M; Toso D; Aebersold R; Nogales E
    Science; 2021 Jan; 371(6527):. PubMed ID: 33479123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9.
    Shirato H; Ogawa S; Nakajima K; Inagawa M; Kojima M; Tachibana M; Shinkai Y; Takeuchi T
    J Biol Chem; 2009 Jan; 284(2):733-9. PubMed ID: 19010785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
    Lavarone E; Barbieri CM; Pasini D
    Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.
    Pasini D; Cloos PA; Walfridsson J; Olsson L; Bukowski JP; Johansen JV; Bak M; Tommerup N; Rappsilber J; Helin K
    Nature; 2010 Mar; 464(7286):306-10. PubMed ID: 20075857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two Functional Axes of Feedback-Enforced PRC2 Recruitment in Mouse Embryonic Stem Cells.
    Perino M; van Mierlo G; Loh C; Wardle SMT; Zijlmans DW; Marks H; Veenstra GJC
    Stem Cell Reports; 2020 Dec; 15(6):1287-1300. PubMed ID: 32763159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.
    Su CL; Deng TR; Shang Z; Xiao Y
    Int J Hematol; 2015 Jul; 102(1):76-85. PubMed ID: 25939703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoregulation of JARID2 through PRC2 interaction with its antisense ncRNA.
    Al-Raawi D; Kanhere A
    BMC Res Notes; 2020 Oct; 13(1):501. PubMed ID: 33126912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
    Shi Y; Ma HL; Zhuang YW; Wang XX; Jiang Y; Xu HE
    Acta Pharmacol Sin; 2019 Nov; 40(11):1457-1465. PubMed ID: 31186533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin.
    Chen S; Jiao L; Liu X; Yang X; Liu X
    Mol Cell; 2020 Mar; 77(6):1265-1278.e7. PubMed ID: 31959557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
    Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
    PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts.
    Yi X; Tao Y; Lin X; Dai Y; Yang T; Yue X; Jiang X; Li X; Jiang DS; Andrade KC; Chang J
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):697-707. PubMed ID: 28130125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PALI1 facilitates DNA and nucleosome binding by PRC2 and triggers an allosteric activation of catalysis.
    Zhang Q; Agius SC; Flanigan SF; Uckelmann M; Levina V; Owen BM; Davidovich C
    Nat Commun; 2021 Jul; 12(1):4592. PubMed ID: 34321472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capturing the Onset of PRC2-Mediated Repressive Domain Formation.
    Oksuz O; Narendra V; Lee CH; Descostes N; LeRoy G; Raviram R; Blumenberg L; Karch K; Rocha PP; Garcia BA; Skok JA; Reinberg D
    Mol Cell; 2018 Jun; 70(6):1149-1162.e5. PubMed ID: 29932905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
    Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
    Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.
    Rosenthal SM; Cheng ZQ
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10307-11. PubMed ID: 7479773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation.
    Laugesen A; Højfeldt JW; Helin K
    Mol Cell; 2019 Apr; 74(1):8-18. PubMed ID: 30951652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycomb repressive complex 2-dependent and -independent functions of Jarid2 in transcriptional regulation in Drosophila.
    Herz HM; Mohan M; Garrett AS; Miller C; Casto D; Zhang Y; Seidel C; Haug JS; Florens L; Washburn MP; Yamaguchi M; Shiekhattar R; Shilatifard A
    Mol Cell Biol; 2012 May; 32(9):1683-93. PubMed ID: 22354997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
    Haynes P; Bomsztyk K; Miller DG
    Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nascent RNA interaction keeps PRC2 activity poised and in check.
    Kaneko S; Son J; Bonasio R; Shen SS; Reinberg D
    Genes Dev; 2014 Sep; 28(18):1983-8. PubMed ID: 25170018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome.
    da Rocha ST; Boeva V; Escamilla-Del-Arenal M; Ancelin K; Granier C; Matias NR; Sanulli S; Chow J; Schulz E; Picard C; Kaneko S; Helin K; Reinberg D; Stewart AF; Wutz A; Margueron R; Heard E
    Mol Cell; 2014 Jan; 53(2):301-16. PubMed ID: 24462204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.